Assure Holdings Expands Service Offerings to Address the High Growth EEG Services Market
The agreement enables the Company to expand its offerings in the field of neurology to include electroencephalogram (“EEG”) testing.
- The agreement enables the Company to expand its offerings in the field of neurology to include electroencephalogram (“EEG”) testing.
- Under the terms of the agreement, Assure has the exclusive rights to offer Neurovative Diagnostics’ comprehensive suite of EEG services to Assure’s current and future hospitals, healthcare facilities and clinics where it provides services.
- Services provided by Neurovative Diagnostics will be treated as ‘fee-for-service’ enabling Assure to leverage Neurovative Diagnostics’ technologists, market knowledge and expertise.
- Assure anticipates the launch of EEG services will occur during the third quarter 2023, leveraging its existing Tele neurology services and requiring minimal working capital needs.